10.1016/0003-9861(83)90602-1 Bohles H, Sewell AC, Wenzel D: The effect of carnitine supplementation in valproate-induced hyperammonaemia
Miled N., 2003
doi: 10.23937/2378-3656/1410150 Summary Keywords euglycemic diabetic ketoacidosis (euDKA), SGLT-2 inhibitor, GLP-1 receptor agonist, type 2 diabetes mellitus, adverse drug reaction Citation Gandecka-Pempera A, Naskrt D, Adamska A and Zozuliska-Zikiewicz D (2025) Severe euglycemic ketoacidosis following combined therapy with GLP-1 receptor agonist and SGLT-2 inhibitor, refractory to standard treatment: a case report
PlexusDx delivers compounded semaglutide injections through licensed 503A pharmacies, making off-label weight loss therapy accessible to all 50 states without insurance requirements
Mounjaro (tirzepatide) activates two receptors: the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor
Which functional groups possess no H-bond donors and no H-bond acceptors
